期刊文献+

CA_(125)、CA_(19.9)、CEA在卵巢上皮性交界性肿瘤中的临床价值 被引量:2

Clinical value of CA_(125),CA_(19.9),and CEA in borderline ovarian tumor.
在线阅读 下载PDF
导出
摘要 目的 :探讨测定血清CA12 5、CA19.9、CEA在诊断卵巢上皮性交界性肿瘤中的临床价值。方法 :回顾分析卵巢交界性肿瘤 5 0例血清CA12 5、CA19.9、CEA水平与临床资料。结果 :浆液性及粘液性肿瘤中CA12 5的阳性率分别为 5 3.85 %和 60 % ,差异无显著性 (P >0 .0 5 ) ,临床分期晚者CA12 5阳性率有增高趋势 ;粘液性肿瘤中CA19.9的阳性率为 4 3.75 % ;CEA阳性率为 12 % ,仅见于粘液性或以粘液性为主的肿瘤中 ;与术前相比 ,术后CA12 5、CA19.9水平及阳性率均显著下降 (P <0 .0 5 )。结论 :CA12 5、CA19.9对卵巢上皮性交界性肿瘤的术前诊断及疗效监测有一定价值 ,CEA则在鉴别组织学类型中有一定价值。 Objective:To investigate the value of serum CA 125 ,CA 19.9 ,and CEA assays in diagnosis of borderline ovarian tumor.Methods:A retrospective analysis of CA 125 ,CA 19.9 and CEA levels in fifty patients with ovarian borderline tumors was performed.Results:The positive rate of CA 125 was 53.85% in serous tumor and 60% in mucinous tumor.The positive rate of CA 19.9 was 43.75% in mucinous tumor.The positive rates of CA 125 in borderline tumors by stage had rising tendency with an increase in each stage.The positive rate of CEA in borderline tumor was 12%,no patients with serous tumors were positive for CEA.The postoperative positive rates and serum levels of CA 125 and CA 19.9 were significantly lower than that of preoperative (P<0.05).Conclusions:Serum CA 125 ,CA 19.9 are important tumor markers for diagnosis of borderline ovarian tumor,and CEA is useful for discrimination of tissue types.
出处 《现代妇产科进展》 CSCD 2001年第5期343-345,共3页 Progress in Obstetrics and Gynecology
关键词 交界性肿瘤 抗原 碳水化合物 癌胚抗原 Borderline neoplasm Antigen,tumor-association,carbohydrates Carcinoembryonic antigen
  • 相关文献

参考文献6

  • 1连利娟.林巧稚妇科肿瘤学[M].人民卫生出版社,1996.306-312.
  • 2妇科常见恶性肿瘤诊断与治疗规范(草案)[J].中华妇产科杂志,1998,33(11):694-704. 被引量:114
  • 3Leake JF,Currie JL,Rosenshein NB,et al.Long-term follow-up of se r ous ovariantumors of low malignant potential[J].Gynecol Oncol,1992,47:150-15 8
  • 4Gotlieb WH,Sorino D,Achiron R,et al.CA125 measurement and ul trasonog raphy inborderline tumors of the ovary[J].Am J Obstet Gynecol,2000,183(3):541 -546
  • 5Tamakoshi K,Kikkwa F,Shibata K,et al.Clinical value of CA125 ,CA19.9 ,CEA,CA72-4and TPA in borderline ovarian tumor[J].Gynecol Oncol,1996,62:67- 72
  • 6Rice LW,Berkowitz RS,Mark SD,et al.Epithelial ovarian tumors of bo rderlinemalignancy[J].Gynecol Oncol,1990,39:195-198

共引文献121

同被引文献10

  • 1王世阆,孙维纲,张国楠.卵巢上皮性交界性肿瘤[J].现代妇产科进展,2006,15(5):321-327. 被引量:2
  • 2段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量:11
  • 3Maltaris T,Boehm D,Dittrich R,et al.Reproduction beyond cancer:A message of hope for young women[J].Gynecol Oncol,2006,103(3):1109.
  • 4Cadron I,Leunen K,Van Grop T,et al.Management of borderline ovarian neoplasms[J].J Clin Oncol,2007,25(20):2928.
  • 5Suh-Burgmann.Long-term outcomes following conservative surgery for bordline tumor of the ovary:a large population-based study[J].Gynecol Oncol,2006,103(3):841.
  • 6Donnez J,Munschke A,Berliere M,et al.Safety of conservative management and fertility outcome in women with borderline tumors of the ovary[J].Fertil Steril,2003,79(5):1216.
  • 7Morice P,Camatte S,Wicart-Poque F,et al.Results of conservative management of epithelial malignant and borderline ovarian tumours[J].Hum Reprod Update,2003,9(1):185.
  • 8Leys D.Neurological protection provided by candesartan:reviewing the latest study results[J].Curr Med Res Opin,2003,19(5):445.
  • 9Morice P,Camatte S,Rey A,et al.Prognostic factors for patients with advanced stage serous borderline tumours of the ovary[J].Ann Oncol,2003,14(2):592.
  • 10Zehra Meltem Pirimoglu,Yasemin Afsin,Kadir Guzelmeric,Muberra Yilmaz,Orhan Unal,Mehmet Cem Turan. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?[J] 2008,Archives of Gynecology and Obstetrics(5):411~414

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部